Core Viewpoint - The medical aesthetics industry is rapidly evolving, driven by advancements in material science, biotechnology, laser technology, and regenerative medicine, leading to a redefined industry ecosystem. A global conference is scheduled for June 12, 2025, in Beijing to foster collaboration and innovation in this field [1]. Group 1: Conference Overview - The "Global Aesthetic Technology Conference 2025" will gather clinical experts, top scientists, innovators, investment institutions, and regulatory bodies to discuss cutting-edge developments, commercialization paths, regulatory trends, and market opportunities in the medical aesthetics sector [2][7]. - The conference will take place at the Beijing Zhongguancun Exhibition Center, accommodating 500 attendees from various sectors, including government, hospitals, and investment institutions [7]. Group 2: Awards and Recognition - The conference will feature the "2025 Global Aesthetic Technology Innovation Award," recognizing significant technological innovations in medical aesthetics with high clinical utility [5]. - The "2025 Global Aesthetic Clinical Excellence Award" will honor products or technologies that have achieved notable results in clinical applications, receiving positive feedback from both doctors and patients [6]. - Additional awards include the "2025 Global Aesthetic Industry Service Award" for outstanding services in technology innovation and the "2025 Global Aesthetic Innovation & Translation Award" for individuals demonstrating exceptional innovation in the field [8][9]. Group 3: Award Evaluation Process - The award evaluation will utilize expert reviews and meetings to determine winners [10]. - The application process for awards is open from now until May 19, 2025, with a structured timeline for submission, evaluation, and notification of winners [13].

Investment Rating - The report rates the beauty and personal care industry as "outperforming the market" [23] Core Insights - In Q1 2025, the fund allocation ratio for the beauty and personal care industry increased slightly, with a total market capitalization of 254.203 billion yuan, up 3.38% from Q4 2024. The total market value of fund holdings in this sector reached 69.182 billion yuan, resulting in a fund allocation ratio of 0.27%, which is an increase of 0.06 percentage points from the previous quarter [11][12] - The individual segments of personal care and medical beauty are in an overweight position, while the cosmetics segment has reached a record low in underweight allocation [3][15] Summary by Sections Fund Allocation Analysis - The beauty and personal care industry saw a fund allocation ratio of 0.27% in Q1 2025, which is an increase of 0.06 percentage points from Q4 2024. The overweight ratio remains at -0.05%, indicating a continued underweight position [11][21] - The personal care segment's fund allocation ratio was 0.09% in Q1 2025, up 0.02 percentage points, with an overweight ratio of 0.03% [15] - The cosmetics segment's fund allocation ratio fell to 0.04%, with an overweight ratio declining to a historical low of -0.12% [15] - The medical beauty segment's fund allocation ratio was 0.13%, with an overweight ratio of 0.03% [15] Top Holdings - The top three stocks in the beauty and personal care sector by fund holding ratio in Q1 2025 are Aimeike, Jinbo Biological, and Stable Medical [16][17] - The total holding ratio of the top ten stocks in this sector was 0.10%, an increase of 0.02 percentage points from the previous quarter [16] Investment Recommendations - The report suggests focusing on cosmetics and medical beauty, as there is significant demand potential in the medium to long term due to the "beauty economy." Regulatory policies favor compliant leading companies in these sectors [21] - For personal care products, the report highlights the growing consumer emphasis on health and care, recommending attention to leading companies with strong R&D capabilities and diverse product matrices [21]

Investment Rating - The report indicates a positive outlook for the textile and apparel industry, with a focus on potential recovery in manufacturing and consumer demand during the upcoming 618 shopping festival [3]. Core Insights - Tariff expectations have eased, with indications from U.S. Treasury Secretary that there is no intention to decouple from China in textiles and related goods, leading to a significant reduction in tariff-related anxiety [3]. - The manufacturing sector is expected to stabilize, with leading manufacturers showing strong resilience and potential for market share growth, particularly companies like Zhejiang Ziran, Kairun, and Huali Group [3]. - The upcoming 618 shopping festival is anticipated to boost domestic consumption, particularly benefiting beauty and personal care brands, as well as discretionary consumer goods [3]. Industry Data Tracking Retail Data - In March, the total retail sales of consumer goods grew by 5.9% year-on-year, with clothing and cosmetics showing growth rates of 3.6% and 1.1%, respectively [17][18]. Raw Material Prices - The Cotlook A index for cotton increased by 0.9% to 13,899, while the Chinese cotton price index decreased by 0.4% to 14,122 [19]. - Polyester filament prices saw increases, with POY, FDY, and DTY rising by 4.0%, 3.1%, and 2.4% respectively [19]. Export Data - Vietnam's textile and apparel exports rose by 14.77% year-on-year in March, with footwear exports increasing by 15.77% [25]. Investment Recommendations - Focus on companies in high-growth sectors with strong fundamentals, such as Anta Sports and 361°, and those with business adjustments leading to high elasticity, like Hailan Home and Semir Apparel [6]. - Retail sector companies like Steady Medical and Dekang Oral are highlighted for their potential dual benefits from consumption boosts and valuation adjustments [6].

2025 年 05 月 12 日 行业周报 看好/维持 纺织服装 纺织服装 纺服&零售周报:制造端有望企稳回升，关注 618 大促催化(2025. 5.5-5.11) ◼ 走势比较 (30%) (20%) (10%) 0% 10% 20% 24/5/13 24/7/24 24/10/4 24/12/15 25/2/25 25/5/8 纺织服装 沪深300 相关研究报告 <<纺服&零售周报：美护品牌 Q1 表现 亮眼，个护景气度向上(2025.4. 28- 5.4)>>--2025-05-06 <<稳健医疗 24 年报及 25Q1 财报点 评：消费品业务加速成长，核心品类 增速亮眼>>--2025-04-29 <<健盛集团 24 年财报点评：业绩符 合预期，期待无缝利润弹性释放>>-- 2025-04-28 证券分析师：郭彬 电话： E-MAIL：guobin@tpyzq.com 分析师登记编号：S1190519090001 报告摘要 本周核心观点：1）关税预期缓和：根据商务部新闻发布，5 月 10 日 上午中美经贸高层会谈在瑞士日内瓦开始举行，中共中央政治局委员、国 务院副总理何立峰作为中美经贸中方牵头人。5 ...

Core Viewpoint - The medical aesthetics industry is rapidly evolving, driven by advancements in material science, biotechnology, laser technology, and regenerative medicine, leading to a reshaping of the industry ecosystem. A global conference is scheduled for June 12, 2025, in Beijing to foster collaboration and innovation in this field [1]. Group 1: Conference Details - The "Global Aesthetic Technology Conference 2025" will take place at the Beijing Zhongguancun Exhibition Center [1]. - The conference aims to gather clinical experts, top scientists, innovators, investment institutions, and government regulators to discuss cutting-edge developments, commercialization paths, regulatory trends, and market opportunities in medical aesthetics [1]. - The expected attendance is around 500 participants from various sectors, including government, hospitals, and upstream and downstream enterprises in the medical aesthetics industry [1]. Group 2: Awards and Recognition - The conference will feature the "2025 Global Aesthetic Technology Innovation Awards" to recognize outstanding contributions in the medical aesthetics technology field [2]. - The awards will include categories such as: - **2025 Global Aesthetic Technology Innovation Award**: For companies and manufacturers demonstrating significant technological innovation with high clinical value [3]. - **2025 Global Aesthetic Clinical Excellence Award**: For products or technologies achieving notable results in clinical applications, receiving positive feedback from both doctors and clients [4]. - **2025 Global Aesthetic Industry Service Award**: For companies and institutions providing exceptional services in technology innovation, clinical trials, and manufacturing within the medical aesthetics sector [5][6]. - **2025 Global Aesthetic Innovation & Translation Award**: For individuals making significant innovative contributions in medical aesthetics, promoting products or solutions with industrialization potential [7]. Group 3: Award Application Process - The application phase for the awards is open from now until May 19, 2025, where companies can submit their materials [10]. - The evaluation phase will occur from May 20 to May 25, 2025, involving material review and expert evaluations [10]. - Winners will be notified between May 26 and May 30, 2025, with awards presented at the conference on June 12, 2025 [10].

Financial Performance - In Q1 2025, the company achieved total revenue of approximately 1.399 billion yuan, a year-on-year decrease of 7.77% [2] - Gross profit margin was 59.72%, an increase of 0.38 percentage points compared to the same period last year [2] - Net profit attributable to shareholders was approximately 61 million yuan, a year-on-year increase of 5.12% [2] - Net profit after deducting non-recurring items was approximately 73 million yuan, a year-on-year decrease of 6.89% [2] - Net cash flow from operating activities was approximately 174 million yuan, a year-on-year decrease of 23.43% [2] - Basic earnings per share were 0.2153 yuan, an increase of 5.13% year-on-year [2] - Return on equity was 3.36% [2] - As of March 31, 2025, total assets were approximately 8.004 billion yuan, a growth of 0.41% from the end of the previous year [3] - Net assets attributable to shareholders were approximately 2.883 billion yuan, an increase of 3.42% from the end of the previous year [3] Business Segment Performance - Medical beauty segment revenue was approximately 670 million yuan, a year-on-year decrease of 9.22% [3] - Medical beauty segment gross profit was approximately 369 million yuan, a decrease of 8.58% year-on-year, with a gross profit margin of 55.05% [3] - Women's clothing segment revenue was approximately 504 million yuan, a year-on-year decrease of 5.74% [3] - Women's clothing segment gross profit was approximately 325 million yuan, with a gross profit margin of 64.51%, an increase of 0.15 percentage points year-on-year [3] - Infant and child segment revenue was approximately 221 million yuan, a year-on-year decrease of 8.52% [3] - Infant and child segment gross profit was approximately 137 million yuan, with a gross profit margin of 62.28%, an increase of 1.78 percentage points year-on-year [3] Brand Performance - Milan Baiyu achieved revenue of approximately 302.62 million yuan, a year-on-year decrease of 8.74% [4] - Jingfu Medical achieved revenue of approximately 125.20 million yuan, a year-on-year increase of 1.13% [4] - Hanchen Medical achieved revenue of approximately 97.93 million yuan, a year-on-year decrease of 1.43% [4] - Wuhan Wuzhou achieved revenue of approximately 47.55 million yuan, a year-on-year decrease of 15.11% [4] - Changsha Yamei achieved revenue of approximately 40.70 million yuan, a year-on-year decrease of 28.61% [4] - Zhengzhou Jimei achieved revenue of approximately 25.68 million yuan, a year-on-year decrease of 16.26% [4] Inventory and Operations - As of Q1 2025, total inventory for women's clothing was approximately 646 million yuan, a decrease of 4.75% from the end of the previous year [5] - The net amount of inventory goods was approximately 512 million yuan, a decrease of 7.45% from the end of the previous year [5] - The structure of inventory improved in Q1 2025 [5]

深圳商报·读创客户端记者 陈燕青 北交所市场今年以来走势强劲，北证50指数涨逾三成，可谓是一枝独秀。继去年四季度后，公募基金今 年一季度继续增持北交所。根据开源证券统计，一季度末公募重仓配置北交所金额创新高，较去年底增 长逾两成。对此，业内人士认为，北交所部分公司在细分领域具有较强的竞争力，中长期值得关注。 开源证券数据显示，一季度末公募重仓配置北交所金额创新高，为67.43亿元，较去年末增长24.45%； 占比公募在A股市值的0.11%，较2024年末增长0.02个百分点。 从公募在北交所配置家数来看，一季度末公募基金在北交所配置家数创新高，有34家公募配置北交所股 票，较去年末增长17.24%。 从被动指数基金规模角度来看，截至4月30日，今年以来北证50指数基金规模为95.39亿元，同比增长 22.63%。截至4月30日，11家北交所主题基金全部公布一季报， 11家基金总规模达43.51亿元，10家北 交所主题产品基金净值在1元以上，11家北交所主题基金今年至今取得平均33.48%的收益，且全部取得 正收益。 据年报统计，在265家北交所上市公司中，31家公司营业收入超过10亿元，超六成公司实现收入正增 ...

Core Insights - The medical beauty sector experienced a slight increase of 0.53% on May 8, with a total capital outflow of 224.7 million [1] - A total of 43 stocks in the sector rose, while 21 stocks declined [1] Top Gainers - The top ten gainers in the sector included: - Aipeng Medical: +13.1% - Haochen Medical: +9.85% - Guangyunda: +9.8% - ST Jingfeng: +5.01% - ST Biological: +4.98% - Hangzhou Jiebai: +4.34% - Langzi Co.: +4.11% - Hanyu Pharmaceutical: +2.7% - Xinyaqiang: +1.57% - Dezhan Health: +1.29% [1] Top Losers - The stocks with the largest declines included: - Hanshang Group: -9.99% - Lafang Cosmetics: -6.79% - Changshan Pharmaceutical: -5.7% - ST Suwu: -4.84% - Chaohongji: -4.75% [1]

Core Viewpoint - Guangdong Province is actively promoting the integration of artificial intelligence with consumption to boost new types of consumption and enhance digital service ecosystems [1] Group 1: New Technology Applications - The government is accelerating the application of new technologies such as AI large models, virtual reality, holographic internet, and digital twins to create integrated digital scenarios [1] - There is a focus on deepening instant e-commerce applications and supporting platforms to build digital life service ecosystems in collaboration with communities and business circles [1] Group 2: Innovation in E-commerce - Support is being provided for live-streaming e-commerce platforms to innovate with virtual hosts and 3D live streaming formats for product promotion [1] Group 3: AI and Consumption Integration - The initiative aims to promote the development and application of new technologies and products such as autonomous driving, smart wearables, ultra-high-definition video, brain-computer interfaces, and additive manufacturing [1] - The application of AI is being demonstrated in typical scenarios including elderly care, education and training, healthcare, government services, home decoration, and shopping payments [1] Group 4: Robotics and Health Consumption - A "Robot+" initiative is being organized to explore consumer application scenarios for robotics [1] - The government is implementing a health consumption initiative to improve remote medical services and enhance the convenience of "Internet + healthcare" services [1] Group 5: Medical Aesthetics Development - There is a focus on the regulated and orderly development of medical aesthetics consumption, promoting emerging fields such as "light medical aesthetics" and anti-aging, while cultivating distinctive medical aesthetics brands [1] - The government plans to collect and publish provincial-level new consumption scenario cases and best practices for service consumption innovation, strengthening promotion efforts [1]

Core Insights - Japan's medical beauty market has surpassed 600 billion yen (approximately 30.2 billion RMB), exceeding that of South Korea, which is known as a "cosmetic surgery powerhouse" [1][3] - The market is expected to continue growing, driven by advancements in medical technology and changing social attitudes towards cosmetic procedures [3][4] Market Size and Growth - The Japanese medical beauty market was valued at 486 billion yen in 2021, representing a 120% increase from the previous year [3] - In 2023, the market is projected to reach 594 billion yen, marking a growth of 108.8% compared to 2022 [3] - From 2009 to 2023, the market has expanded 2.39 times, indicating robust growth [3] Consumer Behavior and Trends - Approximately 70% of surveyed individuals aged 15 to 49 express concern about their appearance, with 43% considering some form of cosmetic medical treatment [4] - The rise of social media has contributed to a more open attitude towards cosmetic procedures, with many celebrities and influencers openly discussing their experiences [3][4] - Non-surgical treatments, such as laser therapy and hyaluronic acid injections, are particularly popular among consumers [4] Demographic Insights - Male consumers are increasingly participating in cosmetic procedures, with treatments like beard removal gaining popularity for their time-saving benefits [4]